The authors are issuing a corrigendum for their article [] to correct information within the Institutional Review Board Statement and the study period. These inaccuracies were the result of an administrative oversight.
Institutional Review Board Statement Correction
The IRB protocol code was erroneously stated. The correct IRB protocol code is 104-3530B, with an approval date of 13 July 2015. The corrected Institutional Review Board Statement appears below:
The study protocol was approved by the Regional Ethical Review Board of Chang Gung Memorial Hospital, Kaohsiung (protocol code: 104-3530B, date of approval: 13 July 2015). Data was collected from September 2015 through April 2021.
Text Correction
Corrections have been made to the study period in the Abstract, Materials and Methods Section and Figure 1: The study period was stated incorrectly. The data for this registry were collected at Chang Gung Memorial Hospital, Kaohsiung, Taiwan, from September 2015 to April 2021.
A correction has been made to the Abstract:
We utilized registry data gathered at Chang Gung Memorial Hospital in Kaohsiung, Taiwan, between September 2015 and April 2021.
A correction has been made to the Materials and Methods, paragraph 1:
A registry was compiled at Chang Gung Memorial Hospital, Kaohsiung (CGMHK), Taiwan, between September 2015 and April 2021.
The corrected Figure 1 appears below:
Figure 1.
Disposition of participants. GC = glucocorticoid. * Exposure of therapy is defined as therapy exposure currently on the index day, or within the previous 6 months before the index day, or within the upcoming 6 months after the index day. Pharmacologic therapy included selective estrogen receptor modulators, oral or intravenous bisphosphonates, denosumab, and teriparatide.
The scientific integrity and conclusions of the study remain unaffected by this correction. The authors regret any confusion this may have caused. This correction was approved by the Academic Editor. The original publication has also been updated.
Reference
- Chen, J.-F.; Yu, S.-F.; Chiu, W.-C.; Ko, C.-H.; Hsu, C.-Y.; Lai, H.-M.; Chen, Y.-C.; Su, Y.-J.; Kang, H.-Y.; Cheng, T.-T. Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. Diagnostics 2024, 14, 452. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).